A Lactobacillus-Deficient Vaginal Microbiota Dominates Postpartum Women in Rural Malawi

Ronan Doyle, Austridia Gondwe, Yue-Mei Fan, Kenneth Maleta, Per Ashorn, Nigel Klein, Kathryn Harris, Ronan Doyle, Austridia Gondwe, Yue-Mei Fan, Kenneth Maleta, Per Ashorn, Nigel Klein, Kathryn Harris

Abstract

The bacterial community found in the vagina is an important determinant of a woman's health and disease status. A healthy vaginal microbiota is associated with low species richness and a high proportion of one of a number of different Lactobacillus spp. When disrupted, the resulting abnormal vaginal microbiota is associated with a number of disease states and poor pregnancy outcomes. Studies up until now have concentrated on relatively small numbers of American and European populations that may not capture the full complexity of the community or adequately predict what constitutes a healthy microbiota in all populations. In this study, we sampled and characterized the vaginal microbiota found on vaginal swabs taken postpartum from a cohort of 1,107 women in rural Malawi. We found a population dominated by Gardnerella vaginalis and devoid of the most common vaginal Lactobacillus species, even if the vagina was sampled over a year postpartum. This Lactobacillus-deficient anaerobic community, commonly labeled community state type (CST) 4, could be subdivided into four further communities. A Lactobacillus iners-dominated vaginal microbiota became more common the longer after delivery the vagina was sampled, but G. vaginalis remained the dominant organism. These results outline the difficulty in all-encompassing definitions of what a healthy or abnormal postpartum vaginal microbiota is. Previous identification of community state types and associations among bacterial species, bacterial vaginosis, and adverse birth outcomes may not represent the complex heterogeneity of the microbiota present. (This study has been registered at ClinicalTrials.gov as NCT01239693.)IMPORTANCE A bacterial community in the vaginal tract is dominated by a small number of Lactobacillus species, and when not present there is an increased incidence of inflammatory conditions and adverse birth outcomes. A switch to a vaginal bacterial community lacking in Lactobacillus species is common after pregnancy. In this study, we characterized the postpartum vaginal bacterial community of a large group of women from a resource-poor, undersampled population in rural Malawi. The majority of women were found to have a Lactobacillus-deficient community, and even when sampled a year after delivery the majority of women still did not have Lactobacillus present in their vaginal microbiota. The effect of becoming pregnant again for those who do not revert to a Lactobacillus-dominant community is unknown, and this could suggest that not all Lactobacillus-deficient community structures are adverse. A better understanding of this complex community state type is needed.

Keywords: 16S rRNA gene; Gardnerella vaginalis; Lactobacillus spp.; postpartum; sub-Saharan Africa; vaginal microbiota.

Copyright © 2018 Doyle et al.

Figures

FIG 1
FIG 1
Study participant flow diagram.
FIG 2
FIG 2
The 25 most prevalent OTUs recovered from participants' vaginal swab samples (n = 994).
FIG 3
FIG 3
(A) Principal-coordinate analysis of Bray-Curtis distances comparing presence of OTUs in participants' vaginal swab samples. Participants are colored based on de novo clustering by the shared presence of OTUs (n = 994). (B) Box-and-whisker plot of the distribution of OTU richness. OTU richness was measured among all five CSTs using the Shannon index. Three asterisks (***) above a CST indicate that the difference between it and all other groups was statistically significant (P < 0.0001) as determined by Student's t test (false discovery rate [FDR]-corrected), and ns indicates there was no statistically significant difference between the Shannon index values in CST 4-II and CST-IV.
FIG 4
FIG 4
Heat map of the relative abundances of 30 OTUs ordered by CST. Each individual is annotated both by the given CST and by HIV status where information was available (n = 994).
FIG 5
FIG 5
(A) Histogram of the number of days after delivery that vaginal samples were collected. (B) The proportion of participants assigned to each CST stratified by how long after delivery samples were taken. Participants were binned into 5 groups: 5 to 20 days (n = 809), 21 to 40 days (n = 98), 41 to 100 days (n = 40), 101 to 200 days (n = 21), and 201 to 583 days (n = 26). P values show where there was a significant pairwise comparison between groups as determined by Fisher's exact test (FDR-corrected). (C) Box-and-whisker plot showing the association between relative abundance of L. iners, G. vaginalis, L. amnionii, and P. anaerobius and how long after delivery the vagina was sampled. P values show where there was a significant pairwise comparison between groups as determined by Student's t test (FDR-corrected).

References

    1. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SSK, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ. 2011. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 108(Suppl 1):4680–4687. doi:10.1073/pnas.1002611107.
    1. Myer L, Denny L, Telerant R, de Souza M, Wright TC Jr, Kuhn L. 2005. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis 192:1372–1380. doi:10.1086/462427.
    1. DiGiulio DB, Callahan BJ, McMurdie PJ, Costello EK, Lyell DJ, Robaczewska A, Sun CL, Goltsman DSA, Wong RJ, Shaw G, Stevenson DK, Holmes SP, Relman DA. 2015. Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci U S A 112:11060–11065. doi:10.1073/pnas.1502875112.
    1. Witkin S. 2015. The vaginal microbiome, vaginal anti-microbial defence mechanisms and the clinical challenge of reducing infection-related preterm birth. BJOG 122:213–218. doi:10.1111/1471-0528.13115.
    1. Donders G, Bellen G, Rezeberga D. 2011. Aerobic vaginitis in pregnancy. BJOG 118:1163–1170. doi:10.1111/j.1471-0528.2011.03020.x.
    1. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG, Rao AV, McNellis D, Regan JA, Carey JC, Klebanoff MA, Vaginal Infections and Prematurity Study Group. 1995. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 333:1737–1742. doi:10.1056/NEJM199512283332604.
    1. Donders G, Van Calsteren K, Bellen G, Reybrouck R, Van den Bosch T, Riphagen I, Van Lierde S. 2009. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 116:1315–1324. doi:10.1111/j.1471-0528.2009.02237.x.
    1. Gratacós E, Figueras F, Barranco M, Vila J, Cararach V, Alonso PL, Fortuny A. 1998. Spontaneous recovery of bacterial vaginosis during pregnancy is not associated with an improved perinatal outcome. Acta Obstet Gynecol Scand 77:37–40.
    1. Vogel I, Thorsen P, Hogan VK, Schieve LA, Jacobsson B, Ferre CD. 2006. The joint effect of vaginal Ureaplasma urealyticum and bacterial vaginosis on adverse pregnancy outcomes. Acta Obstet Gynecol Scand 85:778–785. doi:10.1080/00016340500442423.
    1. Kwak D-W, Hwang H-S, Kwon J-Y, Park Y-W, Kim Y-H. 2013. Co-infection with vaginal Ureaplasma urealyticum and Mycoplasma hominis increases adverse pregnancy outcomes in patients with preterm labor or preterm premature rupture of membranes. J Matern Fetal Neonatal Med 27:333–337. doi:10.3109/14767058.2013.818124.
    1. MacIntyre DA, Chandiramani M, Lee YS, Kindinger L, Smith A, Angelopoulos N, Lehne B, Arulkumaran S, Brown R, Teoh TG, Holmes E, Nicoholson JK, Marchesi JR, Bennett PR. 2015. The vaginal microbiome during pregnancy and the postpartum period in a European population. Sci Rep 5:8988. doi:10.1038/srep08988.
    1. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller A-B, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, Lawn JE. 2012. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 379:2162–2172. doi:10.1016/S0140-6736(12)60820-4.
    1. Goldenberg RL, Culhane JF, Iams JD, Romero R. 2008. Epidemiology and causes of preterm birth. Lancet 371:75–84. doi:10.1016/S0140-6736(08)60074-4.
    1. Oliver RS, Lamont RF. 2013. Infection and antibiotics in the aetiology, prediction and prevention of preterm birth. J Obstet Gynaecol 33:768–775. doi:10.3109/01443615.2013.842963.
    1. Watts DH, Eschenbach DA, Kenny GE. 1989. Early postpartum endometritis: the role of bacteria, genital mycoplasmas, and Chlamydia trachomatis. Obstet Gynecol 73:52–60.
    1. Nugent RP, Krohn MA, Hillier SL. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29:297–301.
    1. Gajer P, Brotman RM, Bai G, Sakamoto J, Schütte UME, Zhong X, Koenig SSK, Fu L, Ma ZS, Zhou X, Abdo Z, Forney LJ, Ravel J. 2012. Temporal dynamics of the human vaginal microbiota. Sci Transl Med 4:132ra52. doi:10.1126/scitranslmed.3003605.
    1. Fettweis JM, Brooks JP, Serrano MG, Sheth NU, Girerd PH, Edwards DJ, Strauss JF, Jefferson KK, Buck GA. 2014. Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology 160:2272–2282. doi:10.1099/mic.0.081034-0.
    1. Chico RM, Mayaud P, Ariti C, Mabey D, Ronsmans C, Chandramohan D. 2012. Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review. JAMA 307:2079–2086. doi:10.1001/jama.2012.3428.
    1. Enwonwu CO, Phillips RS, Falkler WA. 2002. Nutrition and oral infectious diseases: state of the science. Compend Contin Educ Dent 23:431–434, 436, 438 passim; quiz 448.
    1. Hummelen R, Fernandes AD, Macklaim JM, Dickson RJ, Changalucha J, Gloor GB, Reid G. 2010. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One 5:e12078. doi:10.1371/journal.pone.0012078.
    1. Schellenberg JJ, Links MG, Hill JE, Dumonceaux TJ, Kimani J, Jaoko W, Wachihi C, Mungai JN, Peters GA, Tyler S, Graham M, Severini A, Fowke KR, Ball TB, Plummer FA. 2011. Molecular definition of vaginal microbiota in East African commercial sex workers. Appl Environ Microbiol 77:4066–4074. doi:10.1128/AEM.02943-10.
    1. Romero R, Hassan SS, Gajer P, Tarca AL, Fadrosh DW, Bieda J, Chaemsaithong P, Miranda J, Chaiworapongsa T, Ravel J. 2014. The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term. Microbiome 2:18. doi:10.1186/2049-2618-2-18.
    1. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC, Warner B, Reeder J, Kuczynski J, Caporaso JG, Lozupone CA, Lauber C, Clemente JC, Knights D, Knight R, Gordon JI. 2012. Human gut microbiome viewed across age and geography. Nature 486:222–227. doi:10.1038/nature11053.
    1. Misra DP, Trabert B. 2007. Vaginal douching and risk of preterm birth among African American women. Am J Obstet Gynecol 196:140.e1-8. doi:10.1016/j.ajog.2006.10.880.
    1. Brotman RM, Klebanoff MA, Nansel TR, Andrews WW, Schwebke JR, Zhang J, Yu KF, Zenilman JM, Scharfstein DO. 2008. A longitudinal study of vaginal douching and bacterial vaginosis–a marginal structural modeling analysis. Am J Epidemiol 168:188–196. doi:10.1093/aje/kwn103.
    1. Bisanz JE, Enos MK, PrayGod G, Seney S, Macklaim JM, Chilton S, Willner D, Knight R, Fusch C, Fusch G, Gloor GB, Burton JP, Reid G. 2015. Microbiota at multiple body sites during pregnancy in a rural Tanzanian population and effects of Moringa-supplemented probiotic yogurt. Appl Environ Microbiol 81:4965–4975. doi:10.1128/AEM.00780-15.
    1. Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F, Tramontano M, Driessen M, Hercog R, Jung F-E, Kultima JR, Hayward MR, Coelho LP, Allen-Vercoe E, Bertrand L, Blaut M, Brown JRM, Carton T, Cools-Portier S, Daigneault M, Derrien M, Druesne A, de Vos WM, Finlay BB, Flint HJ, Guarner F, Hattori M, Heilig H, Luna RA, van Hylckama Vlieg J, Junick J, Klymiuk I, Langella P, Le Chatelier E, Mai V, Manichanh C, Martin JC, Mery C, Morita H, O'Toole PW, Orvain C, Patil KR, Penders J, Persson S, Pons N, Popova M, Salonen A, Saulnier D, Scott KP, Singh B, Slezak K, Veiga P, Versalovic J, Zhao L, Zoetendal EG, Ehrlich SD, Dore J, Bork P. 2017. Towards standards for human fecal sample processing in metagenomic studies. Nat Biotechnol 35:1069–1076. doi:10.1038/nbt.3960.
    1. Taha TE, Kumwenda NI, Kafulafula G, Makanani B, Nkhoma C, Chen S, Tsui A, Hoover DR. 2007. Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: a randomized clinical trial. PLoS Clin Trials 2:e10. doi:10.1371/journal.pctr.0020010.
    1. Balkus JE, Richardson BA, Rabe LK, Taha TE, Mgodi N, Kasaro MP, Ramjee G, Hoffman IF, Abdool Karim SS. 2014. Bacterial vaginosis and the risk of Trichomonas vaginalis acquisition among HIV-1-negative women. Sex Transm Dis 41:123–128. doi:10.1097/OLQ.0000000000000075.
    1. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7:335–336. doi:10.1038/nmeth.f.303.
    1. Cheung YB. 2013. Statistical analysis of human growth and development, 1st ed CRC Press, Boca Raton, FL.
    1. Fall CHD, Fisher DJ, Osmond C, Margetts BM, Maternal Micronutrient Supplementation Study Group. 2009. Multiple micronutrient supplementation during pregnancy in low-income countries: a meta-analysis of effects on birth size and length of gestation. Food Nutr Bull 30:S533–S546. doi:10.1177/15648265090304S408.
    1. Ashorn P, Alho L, Ashorn U, Cheung YB, Dewey KG, Harjunmaa U, Lartey A, Nkhoma M, Phiri N, Phuka J, Vosti SA, Zeilani M, Maleta K. 2015. The impact of lipid-based nutrient supplement provision to pregnant women on newborn size in rural Malawi: a randomized controlled trial. Am J Clin Nutr 101:387–397. doi:10.3945/ajcn.114.088617.
    1. Doyle RM, Harris K, Kamiza S, Harjunmaa U, Ashorn U, Nkhoma M, Dewey KG, Maleta K, Ashorn P, Klein N. 2017. Bacterial communities found in placental tissues are associated with severe chorioamnionitis and adverse birth outcomes. PLoS One 12:e0180167. doi:10.1371/journal.pone.0180167.
    1. Magoč T, Salzberg SL. 2011. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27:2957–2963. doi:10.1093/bioinformatics/btr507.
    1. Filmer D, Pritchett LH. 2001. Estimating wealth effects without expenditure data—or tears: an application to educational enrollments in states of India. Demography 38:115–132.
    1. Luntamo M, Kulmala T, Mbewe B, Cheung YB, Maleta K, Ashorn P. 2010. Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial. Am J Trop Med Hyg 83:1212–1220. doi:10.4269/ajtmh.2010.10-0264.

Source: PubMed

3
Tilaa